经阴道超声监测药物诱导卵泡发育及排卵的临床应用  

Clinical application of transvaginal ultrasound monitoring drug induced follicular development and ovulation

作　　者：文玉霞 崔淑萍[1] 

机构地区：[1]四平市妇婴医院,吉林省136000

出　　处：《中国实用医药》2014年第16期23-24,共2页China Practical Medicine

摘　　要：目的探讨经阴道超声监测药物诱导卵泡发育及排卵的临床效果。方法对102例经药物治疗不孕症患者进行阴道超声监测,观察其药效。结果 102例患者中使用药物后,经阴道超声显示,卵泡发育成熟排卵有65例,占总比的64.1%;卵泡黄素化未破裂有21例,占总比的20.5%;小卵泡或闭锁有11例,占总比的10.3%;卵巢过度刺激征有5例;占总比的5.1%。结论阴道超声监测可以实时动态观察卵泡发育和排卵一系列过程,有较好直观性,损伤小,准确率高,具有重要的临床应用价值。Objective To explore the clinical effect of transvaginal ultrasound monitoring drug induced follicular development and ovulation. Methods To explore the clinical effect of transvaginal ultrasound monitoring drug induced follicular development and ovulation. In 102 patients after drug treatment of infertility patients were vaginal ultrasound monitoring, to observe its efficacy. Results To explore the clinical effect of transvaginal ultrasound monitoring of drug induced follicular development and ovulation. In 102 patients after drug treatment of infertility patients were vaginal ultrasound monitoring, to observe its efficacy. Drug use in 102 patients, transvaginal scan shows follicular maturation, ovulation in 65 cases,accounted for 64.1%; follicular luteinized unruptured have 21 cases, accounted for 20.5%; small follicles or atresia in 11 cases, accounted for 10.3%;ovarian hyperstimulation syndrome in 5 cases;accounted for 5.1%of the total ratio.Conclusion Transvaginal ultrasound monitoring can be real-time dynamic observation of follicular development and ovulation in a series of process with good intuition, small damage, high accuracy, so it has important clinical application value.

关 键 词：阴道超声 药物诱导排卵 不孕症 

分 类 号：R711.6[医药卫生—妇产科学] R445.1[医药卫生—临床医学]